Northstar Neuroscience, Inc.·4

Mar 13, 7:56 PM ET

Sheffield Deborah L. 4

4 · Northstar Neuroscience, Inc. · Filed Mar 13, 2009

Insider Transaction Report

Form 4
Period: 2009-03-11
Sheffield Deborah L.
VP, Clinical & Regulatory
Transactions
  • Exercise/Conversion

    Common Stock

    2009-03-11$1.72/sh+52,500$90,30064,163 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-03-1148,4964,004 total
    Exercise: $1.72From: 2009-01-31Exp: 2018-03-31Common Stock (48,496 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-03-114,0040 total
    Exercise: $1.72From: 2009-01-31Exp: 2018-03-31Common Stock (4,004 underlying)
  • Exercise/Conversion

    Common Stock

    2009-03-11$1.56/sh+25,500$39,78089,663 total
  • Tax Payment

    Common Stock

    2009-03-11$1.95/sh68,527$133,62821,136 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-03-1125,5000 total
    Exercise: $1.56From: 2009-01-31Exp: 2018-09-14Common Stock (25,500 underlying)
Holdings
  • Common Stock

    10,516
Footnotes (1)
  • [F1]Reflects shares of common stock settled net directly with the Company and withheld by the Company for payment of exercise price and to satisfy tax obligations upon exercise.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT